abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

这页面没有简体中文版本,现以English显示

内容有以下的语言版本: English, 日本語

故事

2021年8月17日

USA: Civil society calls on SEC & other stakeholders to halt technology company Cellebrite going public until human rights compliance demonstrated

Civil society organisations including Access Now and the Committee to Protect Journalists have recorded human rights risks and abuses linked to technology made by Cellebrite, an Israeli digital intelligence firm. In April 2021 Cellebrite announced its intention to become a public company, by entering into an agreement with a special-purpose acquisition company (or SPAC) named TWC Tech Holdings II Corp., which will allow it to be listed on the NASDAQ stock exchange and expand its opportunities for growth.

Alarmed at this deal, in July 2021 a group of civil society organizations and individuals wrote a letter urging the U.S. Securities and Exchange Commission (the SEC), NASDAQ, and other stakeholders to stop the process until Cellebrite demonstrates its commitment to safeguarding human rights. The call follows pressure on key stakeholders from U.S. Member of Congress, Tom Malinowski, due to “urgent concern over unresolved human rights risks linked to the sales history of Cellebrite.”

The Business & Human Rights Resource Centre subsequently raised the letter again with the SEC, Nasdaq, various investors and shareholders linked to the Cellebrite's bid to go public, and invited them to respond to its concerns and recommendations. After we contacted these actors, Cellebrite announced its Registration Statement on Form F-4 has been declared effective by the SEC, but we continued to seek comments on the human rights risks associated with the company’s technologies. None of the stakeholders responded to the request.

企业回应

683 Capital Management, LLC

没有回应

Citadel LLC

没有回应

Crescent Park Management, L.P.

没有回应

Crosslink Capital

没有回应

Empyrean Capital Partners, LP

没有回应

Phoenix Holdings Ltd

没有回应

Glazer Capital, LLC

没有回应

Light Street Capital Management, LLC

没有回应

Makena Capital Management

没有回应

Migdal SAL

没有回应

Millennium Management LLC

没有回应

Nasdaq

没有回应

Park West Asset Management LLC

没有回应

U.S. Securities and Exchange Commission (SEC)

没有回应

Weiss Asset Management LP

没有回应

West Coast Equity Partners LLC

没有回应

Axon Enterprise, Inc.

没有回应

时间线